These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3605413)

  • 21. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amantadine augmentation for refractory obsessive-compulsive disorder: a case report.
    Pasquini M; Berardelli I; Biondi M
    J Clin Psychopharmacol; 2010 Feb; 30(1):85-6. PubMed ID: 20075660
    [No Abstract]   [Full Text] [Related]  

  • 24. Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels.
    Mavissakalian MR; Jones B; Olson S; Perel JM
    J Clin Psychopharmacol; 1990 Aug; 10(4):261-8. PubMed ID: 2286699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
    Mavissakalian M; Jones B; Olson S; Perel JM
    Psychopharmacol Bull; 1990; 26(1):119-22. PubMed ID: 2371366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A predictive study of obsessive-compulsive disorder response to clomipramine.
    Alarcon RD; Libb JW; Spitler D
    J Clin Psychopharmacol; 1993 Jun; 13(3):210-3. PubMed ID: 8354737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tricyclic response in obsessive compulsive disorder.
    Insel TR; Mueller EA; Gillin JC; Siever LJ; Murphy DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):25-31. PubMed ID: 3991911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurologic soft signs in obsessive-compulsive disorder.
    Bihari K; Pato MT; Hill JL; Murphy DL
    Arch Gen Psychiatry; 1991 Mar; 48(3):278-9. PubMed ID: 2036127
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful treatment of obsessive-compulsive disorder with clonidine hydrochloride.
    Knesevich JW
    Am J Psychiatry; 1982 Mar; 139(3):364-5. PubMed ID: 7058953
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract]   [Full Text] [Related]  

  • 31. Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine.
    Ackerman DL; Greenland S; Bystritsky A; Morgenstern H; Katz RJ
    J Clin Psychopharmacol; 1994 Aug; 14(4):247-54. PubMed ID: 7962680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of obsessive-compulsive disorder and trichotillomania to serotonin reuptake blockers.
    Graae F; Gitow A; Piacentini J; Jaffer M; Liebowitz M
    Am J Psychiatry; 1992 Jan; 149(1):149-50. PubMed ID: 1728180
    [No Abstract]   [Full Text] [Related]  

  • 33. Clomipramine (Anafranil) in depressive patients with obsessive neurosis.
    Singh AN; Sexena B; Gent M
    J Int Med Res; 1977; 5 Suppl 5():25-32. PubMed ID: 598603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.
    Pato MT; Hill JL; Murphy DL
    Psychopharmacol Bull; 1990; 26(2):211-4. PubMed ID: 2236458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
    Stern RS; Marks IM; Wright J; Luscombe DK
    Postgrad Med J; 1980; 56 Suppl 1():134-9. PubMed ID: 7393824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clomipramine in autism: preliminary evidence of efficacy.
    McDougle CJ; Price LH; Volkmar FR; Goodman WK; Ward-O'Brien D; Nielsen J; Bregman J; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1992 Jul; 31(4):746-50. PubMed ID: 1644740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clomipramine treatment of possible atypical obsessive-compulsive disorder.
    Cameron OG; Wasielewski P
    J Clin Psychopharmacol; 1990 Oct; 10(5):375-6. PubMed ID: 2258455
    [No Abstract]   [Full Text] [Related]  

  • 38. [Is an obsessive-compulsive disorder in children an anxiety disorder?].
    Jalenques I; Coudert AJ
    Acta Psychiatr Belg; 1989; 89(5-6):325-37. PubMed ID: 2577944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.
    Hanna GL; McCracken JT; Cantwell DP
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):173-8. PubMed ID: 2016218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clomipramine for bowel obsessions.
    Kahne GJ; Wray RW
    Am J Psychiatry; 1989 Jan; 146(1):120-1. PubMed ID: 2912231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.